Article linked with follow up in next post. The FDA wanted to accelerate the process before the normal amount of data and research was collected, and told Pfizer to just submit the data that it had at this point even though Pfizer was following its normal procedure that used to be the norm for the FDA as well.
This is for a mRNA vaccine for babies 4 months to children 4 years old.
Link: https://news.yahoo.com/not-typical-government-takes-unusual-110247787.html
This message has been edited 2 time(s).